Your 2014 membership dues must be paid in full by March 1, 2014 in order to receive the member-discounted registration rates for the World Transplant Congress (WTC)
. No exceptions will be made.
If you are not a member of AST and wish to receive the member-discounted registration rate to the WTC, you must submit your application for membership by January 15, 2014. Late submissions will not be accepted. If your membership is approved, your dues must be paid by March 1, 2014.
Please contact AST Member Services with any questions... Read More...
URGE YOUR MEMBERS OF CONGRESS TODAY TO SUPPORT ROBUST FEDERAL FUNDING FOR NIH AND MEDICAL RESEARCH
As Members of Congress have embarked on a month long August recess period back in their home States and Congressional Districts, it is imperative that they continue to hear from their constituent AST members regarding the unfinished and inadequate approach that Congress has taken thus far with regard to NIH and medical research funding in FY 2014.
As you know, AST's Public Policy Committee and Wash, DC Government Relations office continue to meet daily with Congressional decision-makers on... Read More...
To: primary program administrators, primary physicians, primary surgeons, primary data coordinators, OPTN representatives, and transplant program directors.
Beginning in August, UNOS Data Quality will introduce a new process for verifying with transplant programs the current status (living or dead) of certain candidates waitlisted and recipients transplanted and/or followed post-transplant at the transplant program. This process will involve use of data from other sources to supplement patient status information known to the transplant program. Information in some of these sources must be... Read More...
On July 11th, AST, ASTS, and UNOS were informed by CMS in a teleconference that they are initiating a pilot program called Focused Quality Assessment and Performance Improvement (FQAPI). This new survey strategy will be rolled out starting on Monday, July 15th, and we're told would involve 10 programs initially. It will follow the standard practice of unannounced notice to selected centers. The CMS official assured us that this start would be a pilot and that there would be no citations or 2567's issued in response to the results. The results will be carefully reviewed internally to address... Read More...
The U.S. Food and Drug Administration (FDA) recently approved the New Drug Application (NDA) for ASTAGRAF XL™ (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction. The full press release can be read here
The letter below was organized by the American Society of Transplantation (AST) and the National Kidney Foundation (NKF) to all members of the House Energy & Commerce Committee. The letter was signed by 11 of the transplant stakeholder national organizations and was delivered to Capitol Hill.
Dear Energy and Commerce Committee Members,
As the national stakeholder organizations representing transplant patients, candidates for transplant, and professionals engaged in organ donation and transplantation, we respectively request you co-sponsor H.R. 1428, the Comprehensive Immunosuppressive... Read More...
Post liver transplant metabolic syndrome linked to obesity, diabetes
Factors such as obesity and current and family history of diabetes increased the likelihood of developing metabolic syndrome following liver transplantation in a recent study. Researchers evaluated 84 patients (mean age, 53.9 years; 75 percent men) with cirrhosis before and after undergoing orthotopic liver transplantation (OLT). BMI, waist circumference, blood pressure and nutritional intake were assessed before and three, six and 12 months after transplantation, along with biochemical factors including glucose,... Read More...
Continuous glucose monitoring system (CGMS) in kidney-transplanted children
Pediatric Transplantation (login required)
NODAT and IGT are well-known complications of immunosuppressive therapy after transplantation being a risk factor for cardiovascular disease affecting patient and graft survival. Therefore, early identification and treatment are of high importance. This study examines the glycemic homeostasis of 20 renal-transplanted children using routine laboratory tests and the continuous glucose monitoring system (CGMS). Six patients (30 percent) had IGT, and one patient had NODAT (5... Read More...
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation
Pediatric Transplantation (login required)
FNH is a non-malignant neoplasia of the liver rarely described in children. A significant percentage of the pediatric cases have been reported in patients with a history of malignant disease treated with chemo-radiation therapy and in children who were given HSCT. Little is known about the pathogenesis of FNH in transplanted children, but many risk factors linked to the HSCT procedure have been hypothesized. The detection of hepatic nodules,... Read More...
In a press release sent out yesterday, Representative Lois Capps (CA-24) applauded the House Energy and Commerce Committee's passage of the HOPE Act (H.R. 698, the HIV Organ Policy Equity Act), a bill she authored that would create a science-based path for medical research to proceed on the feasibility, effectiveness and safety of HIV-positive to HIV-positive organ transplants.
AST President, Dr. Daniel Salomon, was quoted in the press release commending the work of Congresswoman Capps to introduce the HOPE Act and for her work in developing the new policy. "On behalf of the American Society... Read More...